Novo-Nordisk A/S (NVO) Stock: Buy, Sell, or Hold?
$40.65
-0.44 (-1.07%)
▼
5d:
+0.87%
30d:
+6.64%
90d:
-11.42%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect NVO Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (49%)
Quality Score
41/100
Position
EXTENDED
30-Day Fair Range
$38.17 – $40.50
Position: EXTENDED
Forward P/E & Valuation
1.8x
CHEAP
vs 2.0x historical avg
Wall Street Target
$45.79
+12.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$39.53 / $43.24
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NVO shows conflicting indicators. Wait for confirmation before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 12, 2026 at $40.52 · last confirmed Nov 12, 2026
Strength: 6.0/10
Get Alerted When NVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$46.63
Based on 0.6% avg growth
INTRINSIC VALUE TODAY
$28.96
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NVO is currently trading at $40.65, which is considered extended relative to its 30-day fair value range of $38.17 to $40.50. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.8) compared to its historical average (2.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NVO is in a strong downtrend. The price is currently testing key support at $39.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $45.79 (+12.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NVO is in a strong downtrend. The price is currently testing key support at $39.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $45.79 (+12.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$38.17 -
$40.50
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Trading Range & Key Levels
30-Day Trading Range
$38.17 -
$40.50
Current vs Trading Range
EXTENDED
Support Level
$39.53
Resistance Level
$43.24
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding NVO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($45.79)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
1.79
Wall Street Target
$45.79
(+12.7%)
Revenue Growth (YoY)
5.6%
Earnings Growth (YoY)
-15.8%
Profit Margin
33.9%
Valuation Discount vs History
-4.0% cheaper
PE vs Historical
1.8 vs 2.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.0%
(market-implied from PE analysis)
1-Year Target
$39.02
(-4%)
2-Year Target
$37.46
(-8%)
3-Year Target
$35.96
(-12%)
3-Yr Target (if PE normalizes)
(PE: 2→2)
$40.20
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -2.9%)
$413.67
(+918%)
Base:
(SPY PE: 1.8, Growth: -2.9%)
$37.27
(-8%)
Bear:
(PE: 1.5, Growth: -2.9%)
$31.68
(-22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (2x PE) as earnings recover.
Trailing PE: 10.38 | Current EPS (TTM): $3.96
Bull Case
$90.40
(+122%)
Analyst growth 100.0%, PE expands to 11.4
Base Case
$82.18
(+102%)
Market implied 100.0%, PE stable at 10.4
Bear Case
$27.94
(-31%)
Severe decline -20.0%, PE contracts to 8.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.8 to 2.0
Stabilization Target:
$45.44
(+11.8%)
PE Expansion Potential:
+11.8%
Share NVO Analysis
Share this live NVO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NVO)
Bullish
3 Retail Mentions
Reddit / WSB Comments
3
Bullish
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on NVO are bullish (sentiment score +0.17) across 3 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:56 PM ET
Data refreshes hourly during market hours. Next update: 7:56 PM
Data refreshes hourly during market hours. Next update: 7:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 55 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 45 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 45 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 54 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 26 SELL |
Advanced NVO Option Strategies
Professional options setups generated by AI based on today's NVO price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NVO Research Pages
